Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on visible light photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112358389B reveals a green LED-driven route for 2-MNQ. Eliminate chromium waste and reduce costs in vitamin K3 manufacturing with our scalable photochemical technology.
Patent CN118388585A enables high-yield amide synthesis with low racemization. Offers supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN118388585A reveals green visible light catalysis for amide synthesis. Reduces racemization and enhances supply chain reliability for pharmaceutical intermediates globally.
Patent CN112358389A details a green LED-driven synthesis of Vitamin K3 intermediate, offering metal-free production and superior purity for reliable supply chains.
Novel ruthenium-catalyzed visible light method for gamma-hydroxy ketones offers mild conditions and high atom economy for pharma intermediates.
Novel ruthenium-catalyzed visible light method for gamma-hydroxy ketones offers mild conditions and high atom economy for pharma intermediates.
Patent CN106977488B reveals visible light promoted synthesis. Offers mild conditions and high purity for pharmaceutical intermediate manufacturing supply chains.
Patent CN112480020A details a green visible light method for synthesizing benzoxazoles. This report analyzes cost reduction and supply chain reliability for pharma intermediates.
Patent CN108586283A enables visible-light synthesis of alpha-azide ketones using air oxidant. Reduces metal waste and offers cost-effective pharmaceutical intermediate manufacturing solutions.
Novel visible-light method for isoquinoline derivatives offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN109705006B reveals a green, visible-light method for diaryl sulfides. Eliminate metal residues and reduce costs in pharmaceutical intermediate manufacturing.
Patent CN116178243A reveals a mild visible-light photocatalytic method for carbazole synthesis, offering significant cost reduction and high purity for pharmaceutical intermediates manufacturing.
Novel photocatalytic trifluoromethylation of aniline drugs improves anticancer activity. Efficient, mild synthesis for reliable pharmaceutical intermediate supply.
Patent CN118772160A reveals a visible-light photocatalytic synthesis for trifluoromethyl dihydropyrroloquinazolinones, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110483345A enables green selective oxidation of thioethers. Discover cost-effective pharmaceutical intermediate manufacturing with mild visible light conditions.
Novel visible light catalytic synthesis method offers mild conditions and environmental safety for high-purity pharmaceutical intermediates manufacturing supply chain.
Patent CN107983349B reveals a visible light catalyst for 1,3-butadiyne synthesis offering green manufacturing and supply chain efficiency for pharmaceutical intermediates.
Patent CN107141248A enables visible light synthesis of 3-sulfonyl spirotrienones. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113072460B details a metal-free visible light method for morpholine oxidative ring-opening, offering cost reduction and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN112812060A reveals metal-free arylation. Offers green synthesis for high-purity pharmaceutical intermediates with simplified supply chains.